-
Signature
-
/s/ Jillian Forusz, as attorney-in-fact
-
Issuer symbol
-
ADBE
-
Transactions as of
-
15 Mar 2024
-
Net transactions value
-
-$257,189
-
Form type
-
4
-
Filing time
-
19 Mar 2024, 16:57:25 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
ADBE |
Common Stock |
Options Exercise |
$0 |
+458 |
+11% |
$0.000000 |
4,531 |
15 Mar 2024 |
Direct |
F1 |
| transaction |
ADBE |
Common Stock |
Tax liability |
$111,788 |
-227 |
-5% |
$492.46 |
4,304 |
15 Mar 2024 |
Direct |
F2 |
| transaction |
ADBE |
Common Stock |
Options Exercise |
$0 |
+62 |
+1.4% |
$0.000000 |
4,366 |
15 Mar 2024 |
Direct |
|
| transaction |
ADBE |
Common Stock |
Tax liability |
$14,774 |
-30 |
-0.69% |
$492.46 |
4,336 |
15 Mar 2024 |
Direct |
F2 |
| transaction |
ADBE |
Common Stock |
Sale |
$130,627 |
-263 |
-6.1% |
$496.68 |
4,073 |
18 Mar 2024 |
Direct |
F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
ADBE |
Restricted Stock Units |
Options Exercise |
$0 |
-458 |
-20% |
$0.000000 |
1,834 |
15 Mar 2024 |
Common Stock |
458 |
$0.000000 |
Direct |
F4 |
| transaction |
ADBE |
Restricted Stock Units |
Options Exercise |
$0 |
-62 |
-20% |
$0.000000 |
248 |
15 Mar 2024 |
Common Stock |
62 |
$0.000000 |
Direct |
F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: